A case of febrile ulceronecrotic Mucha-Habermann's disease successfully treated with oral cyclosporin [18]

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 2, 2007, Pages 272-273

  Kim, Hazel S ^a,b   Yu, D S ^a   Kim, J W ^a  

^a Uijeongbu St Mary's Hospital   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CYCLOSPORIN; DUODERM; LIVER ENZYME; PREDNISOLONE; RECOMBINANT PLATELET DERIVED GROWTH FACTOR; STEROID;

ABDOMINAL PAIN; ALKALINE PHOSPHATASE BLOOD LEVEL; CASE REPORT; DETERIORATION; DRUG DOSE REDUCTION; ENZYME BLOOD LEVEL; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FACE; FEBRILE ULCERONECROTIC MUCHA HABERMANN DISEASE; FEVER; GENITAL SYSTEM; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LETTER; MALE; OUTPATIENT CARE; PAPULE; PITYRIASIS LICHENOIDES; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCAR FORMATION; SCHOOL CHILD; SKIN BIOPSY;

ADMINISTRATION, ORAL; BIOPSY; CHILD; CYCLOSPORINE; DIAGNOSIS, DIFFERENTIAL; FEVER; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PITYRIASIS LICHENOIDES;

EID: 33846361412     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01843.x     Document Type: Letter

References (4)

1. Tsianakas A, Hoeger PH. Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha-Habermann's disease is associated with elevated serum tumor necrosis factor-α. Br J Dermatol 2005; 152: 794-799.
2. Degos R, Duperrat B, Daniel F. Le parapsoriasis ulceronecrotique hyperthermique. Ann Dermatol Venereol 1966; 93: 481-496.
3. Warchauer BL, Maloney ME, Diamond RI. Febrile ulceronecrotic Mucha-Habermann's disease. Arch Dermatol 1983; 119: 597-601.
4. Nakamura S, Nishihara K, Nakayama K, Hoshi K. Febrile ulceronecrotic Mucha-Habermann's disease and its successful therapy with DDS. J Dermatol 1986; 13: 381-384.